European Bank of Induced Pluripotent Stem Cells (EBiSC)

New Global Access to Fully Characterized Human iPSC Lines

EBiSC logoWe are proud to offer the European Bank of Induced Pluripotent Stem Cells (EBiSC) to provide researchers with greater access to more than 350 patient-derived iPSC lines for disease modeling. This portfolio is an extension of our partnership with Public Health England as a distributor of its European Collection of Authenticated Cell Cultures (ECACC) portfolio. We offer a complete solution for the iPSC workflow, including novel reprogramming kits, iPSC culture media, and stem cell antibodies and characterization kits.

Benefits of the EBiSC collection include:

  • >350 Disease Relevant iPSC lines including Parkinson’s, Alzheimer’s, and Isogenic CRISPR edited control lines.
  • Extensively Characterized and Genotyped
  • Robust and Reliable Supply Chain and Product Ordering

EBiSC cell lines will be available to purchase September 2017 through our sales representatives, our award-winning website and global customer service representatives.

 Sign Up for Product Updates